BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 8387097)

  • 1. Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L- leucyl-L-phenylalanine and cyclosporins A, B, C, D, and E.
    Wenzel-Seifert K; Seifert R
    J Immunol; 1993 May; 150(10):4591-9. PubMed ID: 8387097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation.
    Wenzel-Seifert K; Grünbaum L; Seifert R
    J Immunol; 1991 Sep; 147(6):1940-6. PubMed ID: 1653806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
    de Paulis A; Ciccarelli A; de Crescenzo G; Cirillo R; Patella V; Marone G
    J Allergy Clin Immunol; 1996 Jul; 98(1):152-64. PubMed ID: 8765829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formyl peptides and ATP stimulate Ca2+ and Na+ inward currents through non-selective cation channels via G-proteins in dibutyryl cyclic AMP-differentiated HL-60 cells. Involvement of Ca2+ and Na+ in the activation of beta-glucuronidase release and superoxide production.
    Krautwurst D; Seifert R; Hescheler J; Schultz G
    Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):1025-35. PubMed ID: 1281979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopeptides activate Gi-proteins in dibutyryl cyclic AMP-differentiated HL-60 cells.
    Klinker JF; Höer A; Schwaner I; Offermanns S; Wenzel-Seifert K; Seifert R
    Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):245-51. PubMed ID: 8250850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The H1 receptor agonist 2-(3-chlorophenyl)histamine activates Gi proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes.
    Seifert R; Hagelüken A; Höer A; Höer D; Grünbaum L; Offermanns S; Schwaner I; Zingel V; Schunack W; Schultz G
    Mol Pharmacol; 1994 Apr; 45(4):578-86. PubMed ID: 7514261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High constitutive activity of the human formyl peptide receptor.
    Wenzel-Seifert K; Hurt CM; Seifert R
    J Biol Chem; 1998 Sep; 273(37):24181-9. PubMed ID: 9727041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activation of dibutyryl cAMP-differentiated HL-60 human leukemia cells by chemoattractants.
    Klinker JF; Schwaner I; Offermanns S; Hagelüken A; Seifert R
    Biochem Pharmacol; 1994 Nov; 48(10):1857-64. PubMed ID: 7986196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue.
    Seifert R; Höer A; Offermanns S; Buschauer A; Schunack W
    Mol Pharmacol; 1992 Aug; 42(2):227-34. PubMed ID: 1381043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotide-, chemotactic peptide- and phorbol ester-induced exocytosis in HL-60 leukemic cells.
    Wenzel-Seifert K; Seifert R
    Immunobiology; 1990 Nov; 181(4-5):298-316. PubMed ID: 1966023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic effects of cyclosporin A on formyl-methionyl-leucyl-phenylalanine stimulated responses in HL-60 cells differentiated into neutrophils.
    Nguyen NS; Pulido SM; Rüegg UT
    Br J Pharmacol; 1998 Aug; 124(8):1774-80. PubMed ID: 9756396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporins: structure-activity relationships for the inhibition of the human FPR1 formylpeptide receptor.
    Loor F; Tiberghien F; Wenandy T; Didier A; Traber R
    J Med Chem; 2002 Oct; 45(21):4613-28. PubMed ID: 12361388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of leukotriene B4 on enhancement of superoxide production evoked by formyl-methionyl-leucyl-phenylalanine in myeloid differentiated HL-60 cells: possible involvement of intracellular calcium influx and high affinity receptor for leukotriene B4.
    Harada Y
    Hiroshima J Med Sci; 1990 Sep; 39(3):89-94. PubMed ID: 2178158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential uncoupling of chemoattractant receptors from G proteins in retinoic acid-differentiated HL-60 granulocytes.
    Erbeck K; Klein JB; McLeish KR
    J Immunol; 1993 Mar; 150(5):1913-21. PubMed ID: 8382247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of spinorphin, a novel endogenous regulator, on chemotaxis, O2- generation, and exocytosis by N-formylmethionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils.
    Yamamoto Y; Kanazawa T; Shimamura M; Ueki M; Hazato T
    Biochem Pharmacol; 1997 Sep; 54(6):695-701. PubMed ID: 9310346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that activation of a common G-protein by receptors for leukotriene B4 and N-formylmethionyl-leucyl-phenylalanine in HL-60 cells occurs by different mechanisms.
    McLeish KR; Gierschik P; Schepers T; Sidiropoulos D; Jakobs KH
    Biochem J; 1989 Jun; 260(2):427-34. PubMed ID: 2548477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human neutrophils and HL-60 cells do not possess alpha 2-adrenoceptors.
    Musgrave IF; Seifert R
    Biochem Pharmacol; 1994 Jan; 47(2):233-9. PubMed ID: 7905732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR; Grimaldi CM; Furie MB; Fleit HB
    J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotactic peptide receptor-cytoskeletal interactions and functional correlations in differentiated HL-60 cells and human polymorphonuclear leukocytes.
    Rao KM; Currie MS; Cohen HJ; Weinberg JB
    J Cell Physiol; 1989 Oct; 141(1):119-25. PubMed ID: 2550479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
    Nagano C; Azuma A; Ishiyama H; Sekiguchi K; Imagawa K; Kikuchi M
    J Pharmacol Exp Ther; 2001 Apr; 297(1):388-94. PubMed ID: 11259567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.